09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Related
In this episode, Meghan Meade discusses employer obligations towards disabled employees in light of ...
Read More >
DOJ Antitrust Division successfully uses private-style arbitration for first time to block a merger,...
Read More >
The implications of the 2020 election for structured finance are coming into focus. Informed by our ...
Read More >
Employees appreciate employee discounts, tuition reimbursement, prizes of small value, and wellness ...
Read More >
The gift that keeps on giving, the California Supreme Court decision in Dynamex Operations West, Inc...
Read More >
Freddie Mac and Fannie Mae recently announced, in response to the COVID-19 crisis, a new adverse mar...
Read More >